Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy

NCT00886795 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Urticaria

Interventions

DRUG: abatacept (Orencia ®)

Sponsor

Johns Hopkins University

Collaborators

[object Object]